FzioMed's Grant

FzioMed raised a round of funding on November 15, 2005. Investors include National Institute of Arthritis and Musculoskeletal and Skin Diseases.

FzioMed is engaged in the development and commercialization of advanced, absorbable biosurgery products. FzioMed's product platform is an polymer technology called Oxiplex. The properties of Oxiplex m…

Articles about FzioMed's Grant: